Cleared Traditional

K110148 - WEXLER VASCULAR CLAMP SERIES

K110148 is an FDA 510(k) clearance for WEXLER VASCULAR CLAMP SERIES, manufactured by Microsurgical Laboratories,Inc.Dba Wexler Surgical. The device is a Class 2 Cardiovascular device with product code DXC cleared through the Traditional 510(k) pathway after a 91-day FDA review.

K110148 · Microsurgical Laboratories,Inc.Dba Wexler Surgical · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2011
Decision
91d
Days
Class 2
Risk

K110148 is an FDA 510(k) clearance for the WEXLER VASCULAR CLAMP SERIES. Classified as Clamp, Vascular (product code DXC), Class II - Special Controls.

Submitted by Microsurgical Laboratories,Inc.Dba Wexler Surgical (Bellaire, US). The FDA issued a Cleared decision on April 19, 2011 after a review of 91 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.4450 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Microsurgical Laboratories,Inc.Dba Wexler Surgical devices

FDA 510(k) Submission Details - K110148

510(k) Number K110148 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 18, 2011
Decision Date April 19, 2011
Days to Decision 91 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
34d faster than avg
Panel avg: 125d · This submission: 91d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DXC Device Classification - Class 2, Special Controls

Product Code DXC Clamp, Vascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.4450
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXC Clamp, Vascular

All 100
Devices cleared under the same product code (DXC) and FDA review panel - the closest regulatory comparables to K110148.
MICROFRANCE(R) WORMALD VASCULAR CLAMP
K112662 · Medtronic Xomed, Inc. · Jan 2012
EDWARDS LIFESCIENCES INTRACLUDE INTRA-AORTIC CATHETER
K113182 · Edwards Lifesciences, LLC · Dec 2011
EDWARDS LIFESCIENCES ENDOCLAMP AORTIC CATHETER
K112694 · Edwards Lifesciences, LLC · Oct 2011
MODIFICATION TO FEMOSTOP FEMORAL COMPRESSION SYSTEM
K080206 · Radi Medical Systems AB · Feb 2008
TR BAND
K070423 · Terumo Medical Corp. · Mar 2007
D-STAT HANDLE, MODEL 8500-053
K063871 · Vascular Solutions, Inc. · Feb 2007